Bonine for Kids Side Effects
Generic name: cyclizine
Note: This document contains side effect information about cyclizine. Some dosage forms listed on this page may not apply to the brand name Bonine for Kids.
Applies to cyclizine: oral tablet, oral tablet chewable.
Paralysis was reported with IV formulations and typically affected the limbs within minutes of administration. This side effect usually resolved within hours following discontinuation of treatment.[Ref]
Rare (0.01% to 0.1%): Depressed levels of consciousness, loss of consciousness
Frequency not reported: Convulsions, coordination abnormal, decreased consciousness, dizziness, drowsiness, dyskinesia, dystonia, extrapyramidal motor disturbances, generalized chorea, headaches, incoordination, paralysis, paresthesia, somnolence, transient speech disorders, tremor[Ref]
Rare (0.01% to 0.1%): Chills, sensation of heaviness
Rare (0.01% to 0.1%): Pruritus
Auditory and visual hallucinations were reported, especially at doses exceeding recommendations.[Ref]
Frequency not reported: Apnea, bronchospasm, dry nose, dry throat[Ref]
Frequency not reported: Injection site erythema, injection site pain, injection site reactions[Ref]
Injection site reactions included blisters, erythema, pain, thrombophlebitis, and vein tracking.[Ref]
Frequency not reported: Decreased appetite, loss of appetite[Ref]
Frequency not reported: Muscle spasms, twitching[Ref]
Frequency not reported: Blurred vision, oculogyric crisis[Ref]
More about Bonine for Kids (cyclizine)
- Check interactions
- Dosage information
- During pregnancy
- Drug class: anticholinergic antiemetics
Related treatment guides
1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
2. Cerner Multum, Inc. "Australian Product Information." O 0
3. "Product Information. Bonine For Kids (cyclizine)." Heritage/Insight Consumer Products (2019):
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.